Hans‐Rudolf Loosli

Author

Hans‐Rudolf Loosli

Also Known As

H Loosli, H R Loosli, H. LOOSLI, H. Loosli, H. R. LOOSLI, H. R. Loosli, H.-R. Loosli, H.R Loosli, H.R. LOOSLI, H.R. Loosli

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Sanden (Japan)Vrije Universiteit Brussel Goethe University Frankfurt University of Lausanne

About

Hans‐Rudolf Loosli is an author at Sanden (Japan) specializing in biochemistry, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	15	16	1.6K
2	Medicine	13	13	1.6K
3	Natural Sciences	13	14	1.5K
4	Biomolecular Engineering	3	3	191
5	Engineering	2	2	25

Hans‐Rudolf Loosli

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Assignment of carbonyl carbons and sequence analysis in peptides by heteronuclear shift correlation via small coupling constants with broadband decoupling in t1 (COLOC) Horst Kessler, Christian Griesinger, Jutta Zarbock, Journal of Magnetic Resonance (1969) Carbonyl CarbonsHeteronuclear Shift CorrelationBiochemistryProtein FoldingNatural Sciences	1984	547
Cyclosporin A, ein immunsuppressiv wirksamer Peptidmetabolit aus <i>Trichoderma polysporum</i> (L<scp>INK</scp> ex P<scp>ERS</scp>.) <i>Rifai</i> A. Rüegger, Max Kuhn, H. Lichti, Helvetica Chimica Acta	1976	379
Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution Hans‐Rudolf Loosli, Horst Kessler, Hartmut Oschkinat, Helvetica Chimica Acta Molecular RecognitionBiochemistryProtein AssemblyProtein FoldingPeptide Conformations	1985	345
Peptide conformations. Part 30. Assignment of the <sup>1</sup>H‐, <sup>13</sup>C‐, and <sup>15</sup>N‐NMR spectra of cyclosporin A in CDCl<sub>3</sub> and C<sub>6</sub>D<sub>6</sub> by a combination of homo‐ and heteronuclear two‐dimensional techniques Horst Kessler, Hans‐Rudolf Loosli, Hartmut Oschkinat Helvetica Chimica Acta Peptide ConformationsMolecular BiologyCyclosporin APeptide ScienceMolecular Recognition	1985	166
Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites. Gerald Maurer, Hans‐Rudolf Loosli, E. Schreier, Drug Metabolism and Disposition	1984	162
Isolierung und Strukturermittlung der neuen Cyclosporine E, F, G, H und I René Traber, Hans‐Rudolf Loosli, Hans Hofmann, Helvetica Chimica Acta Industrial MycologyMedicinal ChemistryCyclosporins EHeterocyclicBiochemistry	1982	73
Neue Cyclosporine aus <i>Tolypocladium inflatum</i>. Die Cyclosporine K–Z René Traber, Hans Hofmann, Hans‐Rudolf Loosli, Helvetica Chimica Acta Medicinal ChemistryPharmaceutical ScienceCyclosporins K–zBiochemistryNatural Sciences	1987	73
Immunohistological study of malignant diffuse mesotheliomas of the pleura Hans‐Rudolf Loosli, J. Hürlimann Histopathology Alcian BlueMalignant Diffuse MesotheliomasTumoral PathologyMedicineSurgical Pathology	1984	71
Die Struktur von Cyclosporin C René Traber, Max Kuhn, A. Rüegger, Helvetica Chimica Acta Medicinal ChemistryAntifungal AgentBioorganic ChemistryHeterocyclicBiochemistry	1977	63
Neue Cyclopeptide aus <i>Trichoderma polysporum</i> (L<scp>INK EX</scp> P<scp>ERS</scp>.) R<scp>IFAI</scp>: Die Cyclosporine B, D und E René Traber, Max Kuhn, Hans‐Rudolf Loosli, Helvetica Chimica Acta Bioorganic ChemistryAmino AcidsMedicinal FungiSecondary MetabolitePeptide Science	1977	60

Page 1